Atorvastatin Calcium
Product Images NDC 68071-3503

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-3503). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3503 3)

Pdp (68071 3503 3)
Atorvastatin Calcium 10mg tablets packaging label by NuCare Pharmaceuticals, Inc. The label shows 30 oval-shaped tablets with 'ATO' debossed on one side and '10' on the other side. It includes instructions to take the medication at specified intervals and warnings to keep out of reach of children. Manufactured by Umedica Laboratories Pvt. Ltd. in India.*
FDA Label Image

Image Description (Atorvastat Cal Usp Fig 1)

Image Description (Atorvastat Cal Usp Fig 1)
A line graph depicting cumulative incidence percentages over a 3.5-year period comparing Atorvastatin (solid line) and Placebo (dashed line). The graph includes hazard ratio (HR=0.64) with confidence interval and p-value (p=0.0005), illustrating lower cumulative incidence with Atorvastatin versus Placebo.*
FDA Label Image

Image Description (Atorvastat Cal Usp Fig 2)

Image Description (Atorvastat Cal Usp Fig 2)
A Kaplan-Meier plot showing cumulative hazard percentage over time, comparing Atorvastatin and Placebo groups. The x-axis represents time to first primary endpoint over four years of follow-up, and the y-axis shows cumulative hazard percentage. The graph includes hazard ratio and p-value information.*
FDA Label Image

Image Description (Atorvastat Cal Usp Fig 3)

Image Description (Atorvastat Cal Usp Fig 3)
A Kaplan-Meier plot comparing the time to first major cardiovascular endpoint over five years for subjects taking Atorvastatin 10 mg versus 80 mg. The y-axis shows the percentage of subjects experiencing the event, and the x-axis shows time in years. The graph includes hazard ratio and p-value statistics.*
FDA Label Image

Image Description (Atorvastat Cal Usp Structure)

Image Description (Atorvastat Cal Usp Structure)
Chemical structure of atorvastatin calcium showing the molecular arrangement including aromatic rings, fluorine substitution, hydroxyl groups, and calcium ion complexation with three water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.